Leu M1 and S100 in Hodgkin's disease and non-Hodgkin's lymphomas

American Journal of Clinical Pathology
M J KornsteinJ J Brooks

Abstract

Leu M1 positivity of Reed-Sternberg (RS) cells has been reported. The authors studied the specificity and sensitivity of Leu M1 in Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL). Within NHL, they particularly selected cases that were confused with HD. The authors also studied S100 antigen to determine the pattern of staining in HD and NHL. Paraffin-embedded sections of 23 HD cases (3 lymphocyte predominate, 10 nodular sclerosing, 10 mixed cellularity) and 22 NHL cases (13 diffuse large cell, 5 diffuse mixed small and large cell, 4 others) were studied using an ABC technic. In 20 of 23 HD cases, RS cells and variants were Leu M1+; most cases contained prominent paranuclear positivity; some had diffuse cytoplasmic staining; and some had apparent staining of the cell surface. Neutrophils were intensely positive for Leu M1 and occasional histiocytes also were labeled. In two of the three negative cases (MC), the neutrophils were only weakly positive, thus suggesting a problem with tissue preparation. Of 22 NHL cases, 15 were totally Leu M1 negative. In six cases, rare or occasional tumor cells contained Leu M1 positivity in either a weak punctate, granular, or surface pattern. In an additional case, extensive pleomorphic c...Continue Reading

Citations

May 26, 2009·Journal of Applied Oral Science : Revista FOB·Ricardo Alves MesquitaSuzana Cantanhede Orsini Machado de Souza
Apr 15, 1993·Cancer·A C Harris, M J Kornstein
Jan 1, 1987·Virchows Archiv. A, Pathological Anatomy and Histopathology·S SchröderW Böcker
Jan 1, 1990·Virchows Archiv. A, Pathological Anatomy and Histopathology·J TamaruT Takagi
Jan 1, 1989·Virchows Archiv. A, Pathological Anatomy and Histopathology·K HamperG Seifert
Nov 1, 1987·The Journal of Pathology·A de MascarelA Broustet

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.